Long-term outcomes and risk stratification of patency following nitinol stenting in the femoropopliteal segment: Retrospective multicenter analysis

Journal of Endovascular Therapy

Volumn 18, Issue 6, 2011, Pages 753-761

  Iida, Osamu ^a   Soga, Yoshimitsu ^b   Hirano, Keisuke ^c   Suzuki, Kenji ^d   Yokoi, Hiroyoshi ^b   Nobuyoshi, Masakiyo ^b   Muramatsu, Toshiya ^c   Inoue, Naoto ^d   Nanto, Shinsuke ^e   Uematsu, Masaaki ^a  

^a KANSAI ROSAI HOSPITAL   (Japan)

^b KOKURA MEMORIAL HOSPITAL   (Japan)

^c SAISEIKAI YOKOHAMASHI TOBU HOSPITAL   (Japan)

^d Sendai Kosei Hospital   (Japan)

^e OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Balloon angioplasty; Femoropopliteal segment; Nitinol stent; Outcome analysis; Patency; Provisional stenting; Restenosis; Risk stratification; Superficial femoral artery

Indexed keywords

ACETYLSALICYLIC ACID; CILOSTAZOL; CLOPIDOGREL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NITINOL; THIENOPYRIDINE DERIVATIVE; TICLOPIDINE;

ADULT; AGED; ANGIOGRAPHY; ANKLE BRACHIAL INDEX; ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; CRITICAL LIMB ISCHEMIA; DISEASE SEVERITY; DOPPLER ECHOGRAPHY; FEMALE; FEMOROPOPLITEAL BYPASS; FEMOROPOPLITEAL SEGMENT; HAZARD RATIO; HUMAN; IMPLANTATION; IN-STENT RESTENOSIS; LIMB; LIMB INJURY; LIMB ISCHEMIA; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OUTCOME ASSESSMENT; POPLITEAL VEIN; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; STENT; STENT FRACTURE; TREATMENT OUTCOME; VASCULAR PATENCY;

EID: 83455164686     PISSN: 15266028     EISSN: 15451550     Source Type: Journal    
DOI: 10.1583/11-3581.1     Document Type: Article

References (22)

1. Norgren L, Hiatt WR, Dormandy JA, et al.; TASC II Working Group. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). J Vasc Surg. 2007;43:S1-67.
2. Johnston KW. Femoral and popliteal arteries: reanalysis of results of balloon angioplasty. Radiology. 1992;183:767-771.
3. Vroegindeweij D, Vos LD, Tielbeek AV, et al. Balloon angioplasty combined with primary stenting versus balloon angioplasty alone in femoropopliteal obstructions: a comparative randomized study. Cardiovasc Intervent Radiol. 1997;20:420-425. (Pubitemid 27512031)
4. Cejna M, Thurnher S, Illiasch H, et al. Palmaz stent placement in femoropopliteal artery obstructions: a multicenter prospective randomized study. J Vasc Interv Radiol. 2001;12:23-31. (Pubitemid 32097991)
5. Dormandy JA, Rutherford RB. Management of peripheral arterial disease (PAD). TASC Working Group. TransAtlantic Inter-Society Consensus (TASC). J Vasc Surg. 2000;31:S1-S296.
6. Schillinger M, Sabeti S, Loewe C, et al. Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery. N Engl J Med. 2006;354:1879-1888. (Pubitemid 43872689)
7. Dick P, Wallner H, Sabeti S, et al. Balloon angioplasty versus stenting with nitinol stents in intermediate length superficial femoral artery lesions. Catheter Cardiovasc Interv. 2009;74:1090-1095.
8. Sabeti S, Schillinger M, Amighi J, et al. Primary patency of femoropopliteal arteries treated with nitinol versus stainless steel self-expanding stents: propensity score-adjusted analysis. Radiology. 2004;232:516-521. (Pubitemid 38971294)
9. Ranke C, Creutzig A, Alexander K. Duplex scanning of peripheral arteries: correlation of the peak velocity ratio with angiographic diameter reduction. Ultrasound Med Biol. 1992;18:433-440.
10. Laird JR, Katzen BT, Scheinert D, et al. Nitinol stent implantation versus balloon angioplasty for lesions in the superficial femoral artery and proximal popliteal artery: twelve-month results from the RESILIENT randomized trial. Circ Cardiovasc Interv. 2010;3:267-276.
11. Krankenberg H, Schlüter M, Steinkamp HJ, et al. Nitinol stent implantation versus percutaneous transluminal angioplasty in superficial femoral artery lesions up to 10 cm in length: the femoral artery stenting trial (FAST). Circulation. 2007;116:285-292. (Pubitemid 47196564)
12. Duda SH, Bosiers M, Lammer J, et al. Drug-eluting and bare nitinol stents for the treatment of atherosclerotic lesions in the superficial femoral artery: long-term results from the SI-ROCCO trial. J Endovasc Ther. 2006;13:701-710. (Pubitemid 44907633)
13. Dake MD. The Zilver PTX Randomized Trial: 12-month results of a paclitaxel-eluting stent versus balloon angioplasty and bare metal stenting in patients with femoropopliteal artery disease. J Am Coll Cardiol. 2010;56:xii-xvii.
14. Kim SJ, Kim W, Kim JB, et al. Determinants of procedural success and patency following subintimal angioplasty in patients with TASC C and D femoropopliteal arterial disease. Circ J. 2010;74:1959-1964.
15. Iida O, Nanto S, Uematsu M, et al. Cilostazol reduces restenosis after endovascular therapy in patients with femoropopliteal lesions. J Vasc Surg. 2008;48:144-149.
16. Soga Y, Yokoi H, Kawasaki T, et al. Efficacy of cilostazol after endovascular therapy for femoropopliteal artery disease in patients with intermittent claudication. J Am Coll Cardiol. 2009;53:48-53.
17. Iida O, Nanto S, Uematsu M, et al. Long-term results of endovascular therapy with nitinol stent implantation for TASC II A/B femoropopliteal artery lesions: 4 years' experience. Circ J. 2009;73:2143-2147.
18. Scheinert D, Scheinert S, Sax J, et al. Prevalence and clinical impact of stent fractures after femoropopliteal stenting. J Am Coll Cardiol. 2005;45:312-315. (Pubitemid 40094743)
19. Iida O, Nanto S, Uematsu M, et al. Influence of stent fracture on the long-term patency in the femoro-popliteal artery: experience of 4 years. JACC Cardiovasc Interv. 2009;2:665-671.
20. Iida O, Uematsu M, Soga Y, et al. Timing of the restenosis following nitinol stenting in the superficial femoral artery and the factors associated with early and late restenoses. Catheter Cardiovasc Interv. 2011;78:611-617.
21. Soga Y, Iida O, Hirano K, et al. Restenosis after stent implantation for superficial femoral artery disease in patients treated with cilostazol. Catheter Cardiovasc Interv. 2011 Jul 29. [Epub ahead of print]
22. Soga Y, Iida O, Hirano K, et al. Utility of new classification based on clinical and lesional factors after self-expandable nitinol stenting in superficial femoral artery. J Vasc Surg. 2011 Aug 29. [Epub ahead of print]